Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a potent inhibitor of ROCK (Rho-associated protein kinase), which is involved in actin cytoskeleton organization. By inhibiting ROCK, Y-27632 can indirectly affect FAT4 signaling, which is also linked to cytoskeletal dynamics. | ||||||
Thiazovivin | 1226056-71-8 | sc-361380 sc-361380A | 10 mg 25 mg | $278.00 $622.00 | 15 | |
Thiazovivin is a ROCK inhibitor, similar to Y-27632. It can potentially modulate FAT4-related pathways by influencing actin cytoskeleton organization and cellular morphology. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
This compound inhibits the activation of Rac1, a GTPase involved in actin cytoskeleton remodeling. Since FAT4 is associated with cellular morphology, NSC 23766 might influence FAT4 pathways by modulating Rac1 activity. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Blebbistatin is an inhibitor of non-muscle myosin II, which plays a role in cell motility and shape. Its inhibition could indirectly affect FAT4 signaling pathways related to cell adhesion and movement. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. As this pathway can be linked to cadherin-mediated signaling, it may have an indirect impact on FAT4 function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This compound is an inhibitor of JNK, part of the MAPK pathway. By affecting JNK, SP600125 may influence FAT4-related signaling, particularly in stress responses and apoptosis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor. Since PI3K is involved in various signaling pathways, including those related to cell adhesion and migration, it could indirectly impact FAT4 pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Similar to LY294002, Wortmannin is a PI3K inhibitor. Its influence on PI3K-Akt signaling can indirectly affect FAT4-related processes, particularly in cell survival and migration. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. Since mTOR signaling can intersect with pathways involving FAT4, Rapamycin could have an indirect effect. |